跳至主要内容
临床试验/NL-OMON45573
NL-OMON45573已完成4 期

Esophageal HILZO Covered self-expandable metal stent for palliation of malignant dysphagia: A Safety and Feasibility Study - HILZO-study

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Non-operable malignant obstruction of the esophagus or esophagogastric junction, extrinsic malignant compression, or recurrent malignant dysphagia after esophagectomy. A tumor is considered inoperable if the patient has local tumor infiltration in the surrounding organs, distant metastases or a poor general health due to serious concomitant disease.
  • Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal or gastric cardia cancer.
  • Requiring treatment for dysphagia (dysphagia score of 2-4, according to Ogilvie2)
  • Written informed consent
  • Age >= 18 years

排除标准

  • Inappropriate cultural level and understanding of the study.
  • Simultaneous participation in another clinical study
  • Life expectancy of less than 12 months
  • Stenosis after laryngectomy, or if the distance between the upper edge of the stent is less than 2 cm from the upper esophageal sphincter
  • Tumor length of more than 12cm
  • Coagulopathy
  • Previous stent placement for the same condition

研究者

相似试验